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Abstract N-Acetyl-L-D-glucosaminidase (O-GlcNAcase) is a
key enzyme in the posttranslational modi¢cation of intracellular
proteins by O-linked N-acetylglucosamine (O-GlcNAc). Here,
we show that this protein contains two catalytic domains, one
homologous to bacterial hyaluronidases and one belonging to
the GCN5-related family of acetyltransferases (GNATs). Using
sequence and structural information, we predict that the GNAT
homologous region contains the O-GlcNAcase activity. Thus,
O-GlcNAcase is the ¢rst member of the GNAT family not
involved in transfer of acetyl groups, adding a new mode of
evolution to this large protein family. Comparison with solved
structures of di¡erent GNATs led to a reliable structure pre-
diction and mapping of residues involved in binding of the
GlcNAc-modi¢ed proteins and catalysis.
) 2002 Federation of European Biochemical Societies. Pub-
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1. Introduction
The function of many proteins is regulated by posttransla-
tional modi¢cations. This is especially apparent in the case of
signal transduction, where the activity of proteins has to be
¢ne-tuned to react accordingly to intra- and extracellular sig-
nals.
Only recently it became clear, that in addition to phosphor-
ylation of proteins also their glycosylation by O-linked L-N-
acetylglucosamine (O-GlcNAc) might be involved in signal
transduction [1]. In contrast to the more complex N- and O-
linked glycosylation of extracellular proteins, this modi¢ca-
tion is added to serine or threonine residues of intracellular
proteins. A plethora of proteins from species all over the
eukaryotic kingdom has been reported to contain O-GlcNAc.
The development of novel methods usable in proteomics ap-
proaches like antibodies or mass-spectrometry can be ex-
pected to further increase this number.
These studies might add to the increasing evidence of an
implication of O-GlcNAc into di¡erent human diseases like
cancer [2], diabetes [3] and neurodegenerative diseases. Tau
for example, which is a major component of neuro¢brillary
tangles in Alzheimer’s diseased brains, is multiply O-GlcNAc
modi¢ed in normal brains, whereas it is highly phosphorylat-
ed in association with Alzheimer’s disease [4].
Not only this case links glycosylation and phosphorylation,
many di¡erent proteins are modi¢ed by both systems. As the
same types of amino acids are modi¢ed, reciprocity was sus-
pected. Indeed it was shown in di¡erent cases like the oestro-
gen receptor [5] and the protooncogene c-Myc [6], that the
same residues are either phosphorylated or glycosylated. A
¢ne-tuned regulation is crucial for this ‘ying-yang’ relation-
ship. The responsible enzymes are the O-GlcNAc transferase
(OGT) and the N-acetyl-L-D-glucosaminidase (O-GlcNAcase).
The OGT consists of an N-terminal part build of TP repeats
and a C-terminal catalytic unit. In depth sequence analysis
revealed that the catalytic unit is homologous to the glycogen
phosphorylase superfamily [7]. Less is known about the O-
GlcNAcase, which was originally cloned as a putative hyal-
uronidase and only later shown to additionally possess N-
acetylglucosaminidase activity. The region responsible for
the O-GlcNAcase activity has not been mapped and neither
the substrate binding site nor catalytic residues have been
described, hindering detailed experimental characterisation
of the GlcNAcase and restricting the analysis of O-GlcNAc
modi¢cation.
2. Materials and methods
Members of the O-GlcNAcase family were found by BLASTp [8]
searching with the human MGEA5 sequence against NCBI’s non-re-
dundant database. To identify known domains, sequences were
checked against against SMART [9] and Pfam [10]. The C-terminal
sequence of MGEA5 (700^916) was further analysed by PSI-BLAST.
The obtained putative O-GlcNAcase sequences were aligned with
ClustalX [11] and the resulting alignment was manually optimised
in Seaview [12].
Secondary structure elements were predicted by Jpred [13]. To iden-
tify homologues with known structures, intermediate sequence search
[14] was used. Within the N-acetyltransferase family four additional
proteins were selected for a structural alignment: two closely related
GNA5 histone acetyltransferase (PDB Id. 1I12 and 1CJW) and two
aminoglycoside N-acetyltransferases (1bo4 and 1b87) because of their
abilities to bind GlcNAc similar substrates. Pairwise structural align-
ments performed by VAST [15] were obtained from NCBI’s MMDB
[16]. By comparing each of the four structures to each other a multiple
alignment was build based on secondary structure elements.
3. Results
Searches with MGEA5 (gi : 10835356), the ¢rst cloned O-
GlcNAcase [17], against di¡erent domain databases (Pfam
[10], SMART [9]) did not reveal any conserved motif,
although Comtesse et al. [18] report a C-terminal acetyltrans-
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ferase domain found by SMART. Still, a sequence search
using BLASTp [8] against the non-redundant subset of Gen-
Bank found di¡erent, signi¢cant homologous proteins. These
include bacterial hyaluronidases as reported in Heckel et al.
[19] (E-value from 10341 to 3U1038) and a putative acetyl-
transferase (E=3U1038). Inspection of the pairwise align-
ments revealed two regions of homology, separated by a link-
ing sequence. The N-terminal region was homologous to the
hyaluronidases, whereas the similarity to the acetyltransfer-
ases was restricted to the C-terminus.
Iterative BLAST searches with the C-terminal part (aa 700^
916) found di¡erent acetyltransferases. All found proteins
belong to the GCN5-related family of acetyltransferases
(GNAT), for which a couple of structures have been solved
(for review see [20]). Yet, direct searches with the C-terminus
of MGEA5 against the sequences of proteins with known
structure did not reveal signi¢cant similarities. This link could
only be established using intermediate sequence searches [14],
that is, searching with sequences retrieved in previous
searches. For example, the putative acetyltransferase sequence
from Streptomyces coelicolor (gi : 7160091) found in a search
with MGEA5 (E=7U10312) did detect the PDB sequence
1CJW, a serotonin acetyltransferase (E=0.091).
To further strengthen the link between the O-GlcNAcases
and acetyltransferases selected members of the GNAT family
were aligned according to their structures. A secondary struc-
ture prediction based on an alignment of the C-terminal re-
gion of the O-GlcNAcase family revealed a signi¢cant con-
gruence between the secondary structure elements (Fig. 1).
Taken together, these results show that the O-GlcNAcase is
a divergent member of the GNAT family.
The degree of conservation between the GlcNAcase family
and the acetyltransferases varies in di¡erent regions of the
alignment (Fig. 1). The C-terminal region, motif B, is highly
conserved between the GlcNAcases and a subfamily of acetyl-
transferases including glucosamine-6-phosphate N-acetyltrans-
ferases (PDB Id. 1I12) and serotonin N-acetyltransferases
(PDB Id. 1CJW). This region with the consensus FYxxxG is
not present in other GNATs with di¡ering substrates like the
aminoglycoside 3PN-acetyltransferases. Only in the Caeno-
rhabditis elegans sequence, two of these residues have been
‘swapped’. Less conservation can be found in motif A con-
taining the acetyl-CoA binding site of the GNATs which can
be described by the consensus sequence R/QxxGxG/A [21].
This motif is not present in the corresponding region of the
GlcNAcases, which in contrast contain a conserved D not
found in the GNATs.
4. Discussion
4.1. Structure and functional residues of O-GlcNAcase
The human gene encoding a O-GlcNAcase, MGEA5, was
cloned by two independent studies, one purifying a putative
hyaluronidase [19], the other a N-acetylglucosaminidase [17].
 
Fig. 1. Multiple alignment of O-GlcNAcase sequences and structurally characterised members of the acetyltransferase superfamily. Sequences
are labelled with GenBank or PDB identi¢er on the left side, the region of the sequence used in the alignment is given in parentheses on the
lower right side. Numbers in parentheses within the alignment indicate the length of an insert. The upper four sequences (7300721: Drosophila
melanogaster, 17569879: Caenorhabditis elegans, 11024698: Homo sapiens, 21291639: Anopheles gambiae) are representatives of the O-GlcNA-
case family. Sequences from Mus musculus (gi : 14329484) and Rattus norvegicus (gi : 16943639) are not shown, as they are in the aligned region
nearly identical to the human sequence. Conserved residues are coloured and the 80% consensus determined by Chroma [29] is given below
(capital letters represent amino acids, lower case letters: a, aromatic; c, charged; s, small ; p, polar; b, big; h, hydrophobic; 3, negative; +,
positive). A consensus secondary structure prediction for these sequences was obtained from Jpred and is shown in the corresponding line.
K-Helices are denoted by h/H, L-sheets by e/E. Capital letters indicate a reliability score higher than 6. The lower four sequences (1BO4: ami-
noglycoside 3-N-acetyltransferase, 1B87: aminoglycoside 6-N-acetyltransferase, 1CJW: serotonin N-acetyltransferase, 1I12: glucosamine-phos-
phate N-acetyltransferase) belong to the family of Gcn5-related N-acetyltransferases. Structural elements are hallmarked by blue background
for helices or green background for L-sheets. Conserved functional residues are highlighted by bold red characters, conserved residues by bold
characters. Beneath the alignment positions of the four conserved regions are shown that are described as motifs A, B, C and D by Neuwald
et al. [21]
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As the substrates of these enzymes share some similarity, it
was speculated that both reactions are performed by one,
unspeci¢c catalytic centre [18]. Based on sequence similarity
to bacterial proteins, Hanover [22] tentatively assigns this cat-
alytic centre to the N-terminal 300 aa of MGEA5. Here we
showed that MGEA5 contains two regions similar to distinct
enzymes. The N-terminal region is homologous to bacterial
hyaluronidases, whereas the C-terminus shows homology to
acetyltransferases. Evidence that the C-terminal part contains
the N-acetylglucosaminidase activity comes from the observa-
tion that one of the acetyltransferases most similar to
MGEA5 is GNA1. This protein, whose structure has been
solved [23], is involved in the biosynthesis of UDP^GlcNAc
by catalysing the formation of GlcNAc6P. This led to the
question, whether the ability to bind GlcNAc might be con-
served in MGEA5. The region of GNA1 responsible for in-
teraction with GlcNAc6P, commonly denominated Motif B
[21], is highly conserved within the O-GlcNAcases but not
in other acetyltransferases with strongly di¡ering substrates
like aminoglycosides (Fig. 1, sequence 1bo4). The most prom-
inent feature is the conservation of a tyrosine residue, which is
involved in the binding of GlcNAc and the catalytic mecha-
nism of GNA1 [23]. This tyrosine as well as two other posi-
tions is conserved within all members of the O-GlcNAcases.
Taken together, this led to the prediction, that the C-terminal,
acetyltransferase homologous region of MGEA5 is responsi-
ble for binding O-GlcNAc-modi¢ed proteins. Furthermore,
the conserved tyrosine might be involved in the catalytic func-
tion of MGEA5.
Contrasting the well conserved proposed GlcNAc binding
site, regions which are in the classical acetyltransferases in-
volved in acetyl-CoA binding have diverged in the GlcNAc-
ases. Most of the interactions between the acetyltransferases
and acetyl-CoA are performed by a helix termed motif A (Fig.
1). Within this motif, residues which can be described by a Q/
RxxGxG pattern are involved in direct interaction [24]. This
pattern is not conserved in the GlcNAcases. Instead, they
contain a conserved D within the region of this pattern. As,
according to the structures of the GNATs, this residue is
solvent accessible and close to the proposed catalytic tyrosine,
it might either be involved in binding of the O-GlcNAcase-
modi¢ed protein or directly in the catalytic process.
Additional experimental evidence for a C-terminal location
of the N-acetylglucosaminidase comes from a splice variant of
MGEA5, which misses the C-terminal region (MGEA5s). No
in vitro enzymatic activity was found for this variant [25].
Furthermore, the full-length variant is mainly localised in
the cytoplasm, whereas the short form has a nuclear local-
isation [18]. Together with the ¢nding that major parts of
the O-GlcNAcase catalytic activity are present in the cyto-
plasm [25], these experimental results indicate that the cata-
lytic activity is localised in the C-terminal region of MGEA5,
which is homologous to acetyltransferases.
4.2. O-GlcNAcases as linkers of di¡erent regulatory
processes?
Two catalytic functions have been ascribed to MGEA5, a
hyaluronidase [19] and a N-acetylglucosaminidase [25] activ-
ity. The mapping of two independent catalytic domains raises
the question, why these are co-localised in the same protein.
The presence of intracellular hyaluronan, the substrate of hy-
aluronidases, was described only recently and an involvement
in regulatory processes is assumed [26]. The GlcNAc modi¢-
cation also takes part in regulatory mechanisms and is highly
interwoven with phosphorylation [1]. This might indicate that
MGEA5 links two regulatory mechanisms. With the mapping
of the responsible catalytic domains, both processes can now
be studied independent of each other.
The prediction of functional residues for the N-acetylglu-
cosaminidase will allow creating non-functional mutants. As
these should not be able to remove GlcNAc groups from
modi¢ed proteins, they will in£uence the cellular GlcNAcase
modi¢cation state. Complementary to described speci¢c inhib-
itors, these mutants might therefore be usefull in the determi-
nation of proteins, which undergo glycosylation in response to
various stimuli.
4.3. A novel mechanism in the evolution of acetyltransferases
In the evolution of novel enzymes one can imagine two
di¡erent scenarios. Either a protein which has a de¢ned cata-
lytic activity evolves a new substrate a⁄nity or an enzyme
with a given substrate a⁄nity changes the underlying catalytic
mechanism. All so far described members of the GCN5-re-
lated acetyltransferase family transfer an acetyl group from
acetyl-CoA to a wide range of substrates like small molecules
and proteins using a conserved catalytic mechanism [20]. On
the structural level, GNATs are related to N-myristoyltrans-
ferases [27]. Although the transferred molecule is changed, the
major catalytic mechanism and the mode of cofactor binding
are conserved [28]. This indicates that the prevalent mode of
evolution in this superfamily is the change of substrate a⁄nity
by keeping catalytic mechanism and cofactor binding con-
stant. The membership of O-GlcNAcase to the family of ace-
tyltransferases adds a new mode of evolution to this family.
Not only a novel catalytic mechanism has developed but also
cofactor-binding capabilities were lost.
This gives rise to questions about the possible starting point
for this novel invention. One step in the biochemical pathway
leading to UDP^GlcNAc, the substrate that is transferred by
the OGT to a protein, is the addition of an acetyl group to
Glc6P, giving GlcNAc6P. The protein catalysing this step,
GNA1, belongs to the GNAT family and has an a⁄nity for
GlcNAc [23]. Starting from this protein, the O-GlcNAcase
activity might have evolved by changing the underlying cata-
lytic mechanism. Thus, one could imagine a recruitment of
this protein from the metabolic pathway to the regulatory
O-GlcNAc pathway.
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